COMMUNIQUÉS West-GlobeNewswire

InMode Launches AccuTite, Newest Minimally Invasive Technology
15/04/2019
LAKE FOREST, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- InMode Ltd., a leading global provider of innovative, energy-based, minimally invasive solutions, introduces AccuTite, the smallest Radio-Frequency Assisted [...]
Cassava Sciences Completes Patient Enrollment for a Phase 2a Study in Patients with Alzheimer’s Disease
15/04/2019
AUSTIN, Texas, April 15, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, announced the completion of patient enrollment in a clinical study evaluating the safety [...]
Hemostemix Announces Convertible Debenture Financing
15/04/2019
NOT FOR DISTRIBTUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 15, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: [...]
Golden Leaf Holdings Corporate Update
15/04/2019
TORONTO, April 15, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis company built around recognized brands for the wellness and recreational markets [...]
Wildflower and Its Role in Burgeoning CBD Market Featured in NetworkNewsWire Publication
15/04/2019
NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted [...]
Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
15/04/2019
Phase 3 study of AG10 in patients with ATTR-CM (ATTRIBUTE-CM) underway SAN FRANCISCO, April 15, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today reported its financial results for the [...]
INSYS Therapeutics Implements Leadership Changes
15/04/2019
Andrew G. Long Appointed Chief Executive Officer PHOENIX, April 15, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical [...]
Ceapro Inc. Announces Positive Key Findings from Three Oral Presentations Given at European Meeting on Supercritical Fluids
15/04/2019
Research findings from collaboration between University of Alberta and Ceapro on PGX Technology further confirm versatility of PGX Technology and the potential as a platform for delivery systems EDMONTON, Alberta, April [...]
iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System
15/04/2019
Two additional Spanish centers announce adoption of the Xoft System, totaling seven installations across four major regions in Spain Internationally-recognized institutions strengthen portfolio of comprehensive cancer [...]
SI-BONE, Inc. Announces FDA Clearance of iFuse Bedrock™ Novel Spinopelvic Fixation Technology
15/04/2019
SANTA CLARA, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley based medical device company dedicated to solving musculoskeletal disorders of the spinopelvic anatomy, today [...]
TYME Announces USAN Approval of Generic Name “Racemetyrosine” for SM-88
15/04/2019
TYME to Initiate Pivotal Trials for SM-88 in Patients with Metastatic Pancreatic Cancer NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing [...]
Galectin Therapeutics Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of its Registration Statement
15/04/2019
NORCROSS, Ga., April 15, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that it has set key dates and pricing [...]
Todos Medical Enters Into Definitive Agreement With Orot+ for Exclusive Distribution Rights of its Breast Cancer Screening Tests in 2 European Countries
15/04/2019
REHOVOT, Israel, April 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Extendicare Announces April 2019 Dividend of C$0.04 per Share
15/04/2019
MARKHAM, Ontario, April 15, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Dr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical Development
15/04/2019
SAN DIEGO, April 15, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced Ovaprene’s inclusion in a presentation to physicians on the latest forms of novel [...]
Diamond CBD Targets the $130 Billion-Plus Wellness Market at the Orlando Europa Games Expo and Sporting Event
15/04/2019
Company's successful showing demonstrates the strength of its brand in a market which experts predict is growing 10 percent annually FT. LAUDERDALE, Fla., April 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond [...]
Allogene Therapeutics Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715 (an Anti-BCMA AlloCAR T™ Therapy) in Multiple Myeloma
15/04/2019
Anti-BCMA AlloCAR T Cells Maintained Phenotype and Sustained Potent Anti-Tumor Responses After Scaled-Up Manufacturing ALLO-715 Investigational New Drug Application and Phase 1 Trial Initiation Expected in 2019 SOUTH [...]
Achaogen Plans for Near-Term Sale Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code
15/04/2019
Bidding process and auction projected to conclude June 2019 SOUTH SAN FRANCISCO, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company developing and commercializing [...]
Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs
15/04/2019
TORONTO, April 15, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries ") a Latin American licenced producer of medicinal cannabis and cannabis- [...]

Pages